Bausch Health Companies (BHC) Long-Term Investments (2009 - 2012)
Bausch Health Companies (BHC) posted Long-Term Investments of $7.2 million for Q4 2012, down 21.84% sequentially from $9.2 million in Q2 2011.
Bausch Health Companies (BHC) Long-Term Investments (2009 - 2012) Analysis & Trends
Bausch Health Companies has reported Long-Term Investments for 4 years, with the latest figure at $7.2 million in Q4 2012.
- Quarterly Long-Term Investments changed N/A year-over-year to $7.2 million in Q4 2012, while the trailing twelve-month figure through Dec 2012 was $7.2 million (changed N/A YoY) and the FY2012 annual result came in at $7.2 million, changed N/A from the prior year.
- Long-Term Investments fell to $7.2 million in Q4 2012 per BHC's latest filing, from $9.2 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $80.0 million in Q1 2011 and troughed at $2.1 million in Q4 2010.
- A 4-year average of $17.6 million and a median of $9.2 million in 2011 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2010 and 2011: Long-Term Investments slumped 81.91% in 2010, then retreated 5.07% in 2011.
- Over 4 years, Long-Term Investments stood at $11.5 million in 2009, then plunged by 81.91% to $2.1 million in 2010, then surged by 340.23% to $9.2 million in 2011, then slipped by 21.84% to $7.2 million in 2012.
- According to Business Quant data, Long-Term Investments over the past three periods registered $7.2 million, $9.2 million, and $80.0 million for Q4 2012, Q2 2011, and Q1 2011 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 60.00 Mn |
| 10 | Bausch Health Companies | 2.42 Bn | 586.38 Mn | 2.10 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 7.17 Mn |
| Jun 30, 2011 | 9.17 Mn |
| Mar 31, 2011 | 79.95 Mn |
| Dec 31, 2010 | 2.08 Mn |
| Sep 30, 2010 | 3.65 Mn |
| Jun 30, 2010 | 9.66 Mn |
| Dec 31, 2009 | 11.52 Mn |